Literature DB >> 4087168

Analysis of methadone disposition in the pregnant rat by means of a physiological flow model.

J L Gabrielsson, P Johansson, U Bondesson, L K Paalzow.   

Abstract

A physiological flow model simulating the pregnant rat is constructed for methadone. The model includes brain, fetal, hepatic, intestinal, muscular, pulmonar, and renal tissues. Since methadone kinetics may provide valuable information for optimal therapy, an attempt is made to describe methadone kinetics in brain and other tissues simultaneously. The concentration-time profiles of methadone in various tissues after an i.v. bolus dose of 2 mg/kg are reasonably described by the model. The role of the different organs in the disposition of methadone is further explored by simulations. It is found that methadone is initially sequestered in lung tissues immediately after intravenous administration. Therefore, both venous and arterial blood pools are included in the model. Rapid uptake then takes place into vascular-rich organs, including kidneys, liver, and muscle, followed by redistribution into less penetrable organs, such as brain, fetal, and intestinal tissues. Data indicate that diffusional resistance governs the transfer of drug into brain, fetal, and intestinal tissues. Simulations suggest that muscular tissues play an important role in the rat and in man, becoming the major methadone reservoir. The tissue-to-blood partition coefficients derived from equilibrium conditions in this study are generally higher than those reported hitherto. The model is scaled up to a human to investigate whether it can be used to predict the concentration of methadone in different organs after a certain dose. Volume of distribution (Vdss) and biological half-life are consistent with earlier findings in man. The study is done by means of the GC-MS method with selected ion-monitoring where deuterated methadone is used as an internal standard.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4087168     DOI: 10.1007/BF01061474

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  24 in total

1.  Pharmacologic basis for the increased sensitivity of the newborn rat to morphine.

Authors:  H J KUPFERBERG; E L WAY
Journal:  J Pharmacol Exp Ther       Date:  1963-07       Impact factor: 4.030

2.  Treatment of the morphine abstinence syndrome with 10820 (4-4-diphenyl-6-dimethylamino-heptanone-3).

Authors:  H ISBELL; A J EISENMAN
Journal:  Fed Proc       Date:  1947

3.  Microelectrometric titration measurement of the pKa's and partition and drug distribution coefficients of narcotics and narcotic antagonists and their pH and temperature dependence.

Authors:  J J Kaufman; N M Semo; W S Koski
Journal:  J Med Chem       Date:  1975-07       Impact factor: 7.446

4.  The distribution of methadone in the nonpregnant, pregnant and fetal rat after acute methadone treatment.

Authors:  M A Peters; M Turnbow; D Buchenauer
Journal:  J Pharmacol Exp Ther       Date:  1972-05       Impact factor: 4.030

5.  Age-dependent alterations in the accumulation of l-methadone in the brain synaptosomes and other subcellular fractions.

Authors:  N S Shah; A B Shah
Journal:  Dev Pharmacol Ther       Date:  1984

6.  A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE.

Authors:  V P DOLE; M NYSWANDER
Journal:  JAMA       Date:  1965-08-23       Impact factor: 56.272

7.  Circulatory changes during pregnancy in spontaneously and renal hypertensive rats.

Authors:  Y Lundgren; K Karlsson; U Ljungblad
Journal:  Clin Sci (Lond)       Date:  1979-12       Impact factor: 6.124

8.  A physiological pharmacokinetic model for morphine disposition in the pregnant rat.

Authors:  J L Gabrielsson; L K Paalzow
Journal:  J Pharmacokinet Biopharm       Date:  1983-04

9.  Postoperative pain control with methadone: influence of supplementary methadone doses and blood concentration--response relationships.

Authors:  G K Gourlay; R J Willis; P R Wilson
Journal:  Anesthesiology       Date:  1984-07       Impact factor: 7.892

10.  Methadone: radioimmunoassay and pharmacokinetics in the rat.

Authors:  G S Ling; J G Umans; C E Inturrisi
Journal:  J Pharmacol Exp Ther       Date:  1981-04       Impact factor: 4.030

View more
  12 in total

1.  Relationship of apparent systemic clearance to individual organ clearances: effect of pulmonary clearance and site of drug administration and measurement.

Authors:  R Mehvar
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

2.  Population-based analysis of methadone distribution and metabolism using an age-dependent physiologically based pharmacokinetic model.

Authors:  Feng Yang; Xianping Tong; D Gail McCarver; Ronald N Hines; Daniel A Beard
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-06-07       Impact factor: 2.745

3.  An extended physiological pharmacokinetic model of methadone disposition in the rat: validation and sensitivity analysis.

Authors:  J L Gabrielsson; T Groth
Journal:  J Pharmacokinet Biopharm       Date:  1988-04

4.  Tissue distribution of fentanyl and alfentanil in the rat cannot be described by a blood flow limited model.

Authors:  S Björkman; D R Stanski; H Harashima; R Dowrie; S R Harapat; D R Wada; W F Ebling
Journal:  J Pharmacokinet Biopharm       Date:  1993-06

5.  The acute disposition of (R)- and (s)-methadone in brain and lung of sheep.

Authors:  David J R Foster; Richard N Upton; Andrew A Somogyi; Cliff Grant; Allison Martinez
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-08       Impact factor: 2.745

6.  First-pass effect of cis-3,4-dichloro-N-methyl-N-(2-(1-pyrrolidinyl)- cyclohexyl)-benzamide (U-54494) in rats--a model with multiple cannulas for investigation of gastrointestinal and hepatic metabolism.

Authors:  W Z Zhong; M G Williams; K J Cook; T L VandeGiessen; B W Jones; K E Rousch
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

7.  Comparative physiological pharmacokinetics of fentanyl and alfentanil in rats and humans based on parametric single-tissue models.

Authors:  S Björkman; D R Wada; D R Stanski; W F Ebling
Journal:  J Pharmacokinet Biopharm       Date:  1994-10

8.  Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125.

Authors:  R Kawai; M Lemaire; J L Steimer; A Bruelisauer; W Niederberger; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1994-10

9.  Modeling methadone pharmacokinetics in rats in presence of P-glycoprotein inhibitor valspodar.

Authors:  Ignacio Ortega; Monica Rodriguez; Elena Suarez; Juan Jose Perez-Ruixo; Rosario Calvo
Journal:  Pharm Res       Date:  2007-03-23       Impact factor: 4.580

10.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.